TipRanks
Go Ultimate55% OFF

John A III Stalfort Insider Profile

18 Followers

John A III Stalfort, Director at Acumen Pharmaceuticals, holds 220.62K shares in Acumen Pharmaceuticals (Ticker: ABOS), holds 2.06M shares in Taysha Gene Therapies (Ticker: TSHA), holds 1.87M shares in Verrica Pharmaceuticals (Ticker: VRCA).

John A III Stalfort's Trading History

ABOS
Acumen Pharmaceuticals
Jun 05, 2026DirectorUninformative Buy―$46.33K
TSHA
Taysha Gene Therapies
Jun 02, 2026DirectorUninformative Buy―$8.51M
VRCA
Verrica Pharmaceuticals
Nov 26, 2024DirectorUninformative Buy―$6.28M
DOVA
Dova Pharmaceuticals
Nov 12, 2019―Uninformative Sell17.48M$0.00

You May Also Like

John A III Stalfort insider profile FAQ

What is the percentage of profitable transactions made by John A III Stalfort?
The percentage of profitable transactions made by John A III Stalfort is 80%.
What is the average return per transaction made by John A III Stalfort?
The average return per transaction made by John A III Stalfort is 29.80%.
What stocks does John A III Stalfort hold?
John A III Stalfort holds: ABOS, DOVA, VRCA, TSHA stocks.
What was John A III Stalfort's most profitable transaction?
John A III Stalfort’s most profitable transaction was an Informative Buy of VRCA stock on July 5, 2022. The return on the trade was 136.80%.
What is John A III Stalfort's role in Acumen Pharmaceuticals?
John A III Stalfort's role in Acumen Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.